Abstract
Chemotherapy-associated myelosuppression and renal dysfunction is not uncommon during childhood acute lymphoblastic leukemia (ALL) therapy. Here we report 2 cases of atypical hemolytic uremic syndrome (aHUS) presenting with pancytopenia and renal dysfunction that developed during maintenance chemotherapy characterized by hypocomplementemia. Both cases experienced recurrence after resolution of the initial aHUS episode upon resumption of chemotherapy, raising a possible contributory role for chemotherapy in the disease pathogenesis.
Original language | English |
---|---|
Pages (from-to) | 560-562 |
Number of pages | 3 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 40 |
Issue number | 7 |
DOIs | |
State | Published - Oct 1 2018 |
Keywords
- acute lymphoblastic leukemia
- atypical hemolytic uremic syndrome
- chemotherapy
- complement